Substituted benzoylguanidines, their use as a medicament or diag

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514400, 514407, 514427, 546332, 5483361, 5483751, 548561, C07D21302, A61K 3144

Patent

active

057191697

ABSTRACT:
The invention relates to benzoylguanidines of the formula I: ##STR1## to pharmaceutically acceptable salts of these compounds and to a process for preparing compounds of the formula I, which comprise reacting a compound of the formula II ##STR2## with guanidine. The compounds of the invention are suitable as antiarrhythmic pharmaceuticals having a cardioprotective component for the prophylaxis and treatment of infarction and for the treatment of angina pectoris.

REFERENCES:
patent: 3780027 (1973-12-01), Cragoe et al.
patent: 5091394 (1992-02-01), Englert et al.
patent: 5292755 (1994-03-01), Englert et al.
Derwent Abstract of WO 93/04048, 1993.
A. Schomig et al., "Inhibition of Na.sup.+ /H.sup.+ exchange suppresses noradrenaline release and arrhythmias in the ischemic rat heart, " Eur. Heart J. 9(suppl. 1): 167 (1988), Book of abstracts.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Substituted benzoylguanidines, their use as a medicament or diag does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted benzoylguanidines, their use as a medicament or diag, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted benzoylguanidines, their use as a medicament or diag will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1784325

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.